RecruitingNot ApplicableNCT05195385

Lung Cancer Screening With Low-dose CT Scan in Women : Implementation Study

Sponsor

Assistance Publique - Hôpitaux de Paris

Enrollment

2,635 participants

Start Date

Apr 8, 2022

Study Type

INTERVENTIONAL

Conditions

Lung Cancer Screening

Summary

The purpose of this study is to determine whether reading of low-dose thoracic CT scans can be done by a single general radiologist who has been trained to lung cancer screening, and will evaluate the performance in comparison with double reading by experts. The study will enroll women between 50 and 74 years old, at risk for lung cancer due to their smoking history.

Eligibility

Sex: FEMALEMin Age: 50 YearsMax Age: 74 Years

Plain Language Summary

Simplified for easier understanding

This trial studies how well lung cancer screening with low-dose CT scans works in women who have a significant smoking history. You may be eligible if... - You are a woman aged 50 to 74 - You smoked at least 20 pack-years and quit less than 15 years ago - You have given consent and can commit to a 2-year follow-up - You are enrolled in the French social security system You may NOT be eligible if... - You have symptoms that suggest cancer (e.g., weight loss, coughing up blood) or an active infection - You have an active cancer or history of lung cancer - A 2-year follow-up is not possible for you - You had a chest CT scan within the last 2 years Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURELow-dose computed tomography of the chest

Baseline low dose Ct acquisition, then at 1 year and 2 years to depict suspicious lung nodules

Locations(1)

Hôtel-Dieu

Paris, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05195385

Related Trials

LUNG-07: Advancing Precision-Based Lung Cancer Screening: Implementation, AI-Guided Risk Stratification, and Biomarker Integration (CREST AI)

NCT074085312 locations

Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Lung Cancer

NCT070086641 location